CLINICAL_TRIALS
trial_result
· 2022-11-16
Clinical Trial Update: Safety and Efficacy of Dexmedetomidine (DEX) for Sedation of Subjects ≥1 Month to <17 Years Undergoing MRI Scans [Phase 4]
Summary
Phase 4 clinical trial assessing safety and efficacy of dexmedetomidine for sedation in pediatric patients undergoing MRI shows completed results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: MRI Sedation | Phase 4 | Status: COMPLETED | Results posted: 2022-11-16